Department of Nephrology, Saku Central Hospital, Nagano, Japan.
Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Am J Nephrol. 2023;54(3-4):83-94. doi: 10.1159/000529991. Epub 2023 Mar 14.
Vascular access usage varies widely across countries. Previous studies have evaluated the association of clinical outcomes with the three types of vascular access, namely, arteriovenous fistula (AVF), arteriovenous graft (AVG), and tunneled and cuffed central venous catheter (TC-CVC). However, little is known regarding the association between arterial superficialization (AS) and the mortality of patients.
A nationwide cohort study was conducted using data from the Japanese Society for Dialysis Therapy Renal Data Registry (2006-2007). We included patients aged ≥20 years undergoing hemodialysis with a dialysis vintage ≥6 months. The exposures of interest were the four types of vascular access: AVF, AVG, AS, and TC-CVC. Cox proportional hazard models were used to evaluate the associations of vascular access types with 1-year all-cause and cause-specific mortality.
A total of 183,490 maintenance hemodialysis patients were included: 90.7% with AVF, 6.9% with AVG, 2.0% with AS, and 0.4% with TC-CVC. During the 1-year follow-up period, 13,798 patients died. Compared to patients with AVF, those with AVG, AS, and TC-CVC had a significantly higher risk of all-cause mortality after adjustment for confounding factors: adjusted hazard ratios (95% confidence intervals) - 1.30 (1.20-1.41), 1.56 (1.39-1.76), and 2.15 (1.77-2.61), respectively. Similar results were obtained for infection-related and cardiovascular mortality.
This nationwide cohort study conducted in Japan suggested that AVF usage may have the lowest risk of all-cause mortality. The study also suggested that the usage of AS may be associated with better survival rates compared to those of TC-CVC in patients who are not suitable for AVF or AVG.
血管通路的使用在各国之间存在很大差异。先前的研究已经评估了三种血管通路(动静脉瘘(AVF)、动静脉移植物(AVG)和隧道和带袖中央静脉导管(TC-CVC))与临床结局之间的关联。然而,关于动脉浅表化(AS)与患者死亡率之间的关联知之甚少。
使用日本透析治疗学会肾脏数据登记处(2006-2007 年)的数据进行了一项全国性队列研究。我们纳入了年龄≥20 岁、接受血液透析且透析龄≥6 个月的患者。感兴趣的暴露因素是四种血管通路类型:AVF、AVG、AS 和 TC-CVC。Cox 比例风险模型用于评估血管通路类型与 1 年全因和特定原因死亡率之间的关联。
共纳入 183490 例维持性血液透析患者:90.7%为 AVF,6.9%为 AVG,2.0%为 AS,0.4%为 TC-CVC。在 1 年的随访期间,有 13798 名患者死亡。与 AVF 患者相比,AVG、AS 和 TC-CVC 患者在调整混杂因素后,全因死亡率的风险显著更高:调整后的危险比(95%置信区间)-1.30(1.20-1.41)、1.56(1.39-1.76)和 2.15(1.77-2.61)。感染相关和心血管死亡率也得到了类似的结果。
这项在日本进行的全国性队列研究表明,AVF 的使用可能具有最低的全因死亡率风险。该研究还表明,与不适合 AVF 或 AVG 的患者相比,AS 的使用可能与更好的生存率相关,而不是 TC-CVC。